Skip to main content

Advertisement

Table 1 Demographic and Anthropometric Characteristics of the Sample

From: Correlates of weight gain during long-term risperidone treatment in children and adolescents

Characteristic
Age, years 11.8 (±2.9)
Males, n (%) 98 (89%)
Tanner Stage: I, II, III, IV, V (%) 36/14/18/22/10
Race, n (%)  
  White 87 (79)
  African American 17 (15)
  Hispanic 5 (5)
  Other 1 (1)
Anthropometric/Metabolic Data
Birth Weight z Scorea (n=98) -0.29 (±0.99)
Baseline Weight z Scoreb 0.17 (±1.02)
Baseline BMI z Scoreb (n=107) 0.18 (±1.05)
Enrollment Weight, Kg 49.1 (±18.3)
Enrollment Weight z Score 0.72 (±1.03)
Enrollment Weight, Kg/m2 20.9 (±4.6)
Enrollment BMI z Score 0.73 (±1.02)
  1. a This was adjusted for sex and gestational age [31].
  2. b Baseline sex- and age-adjusted weight or body mass index (BMI) z scores included those available upon or within the month prior to starting risperidone.